X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4803) 4803
Book Review (651) 651
Publication (388) 388
Newsletter (83) 83
Conference Proceeding (35) 35
Book Chapter (9) 9
Magazine Article (9) 9
Dissertation (5) 5
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3824) 3824
humans (3345) 3345
clarithromycin (3045) 3045
helicobacter pylori (1839) 1839
male (1773) 1773
female (1749) 1749
helicobacter infections - drug therapy (1558) 1558
anti-bacterial agents - therapeutic use (1397) 1397
helicobacter pylori - drug effects (1340) 1340
middle aged (1336) 1336
microbiology (1329) 1329
infection (1311) 1311
adult (1283) 1283
anti-bacterial agents - pharmacology (1238) 1238
gastroenterology & hepatology (1185) 1185
clarithromycin - therapeutic use (1152) 1152
pharmacology & pharmacy (1077) 1077
clarithromycin - pharmacology (1048) 1048
drug therapy, combination (1042) 1042
microbial sensitivity tests (1035) 1035
aged (962) 962
amoxicillin (915) 915
treatment outcome (859) 859
metronidazole (820) 820
resistance (803) 803
eradication (800) 800
infectious diseases (776) 776
helicobacter infections - microbiology (763) 763
antibiotics (743) 743
drug resistance, bacterial (718) 718
anti-bacterial agents - administration & dosage (635) 635
clarithromycin - administration & dosage (610) 610
triple therapy (601) 601
antibiotic-resistance (585) 585
amoxicillin - therapeutic use (549) 549
helicobacter pylori - isolation & purification (544) 544
therapy (522) 522
adolescent (515) 515
prevalence (462) 462
infections (461) 461
clarithromycin resistance (457) 457
drug resistance, microbial (455) 455
omeprazole (448) 448
helicobacter pylori - genetics (444) 444
azithromycin (425) 425
helicobacter infections (411) 411
drug resistance (408) 408
management (399) 399
antimicrobial resistance (393) 393
levofloxacin (392) 392
susceptibility (382) 382
amoxicillin - administration & dosage (380) 380
efficacy (380) 380
health aspects (378) 378
prospective studies (374) 374
drug resistance in microorganisms (357) 357
metronidazole - therapeutic use (352) 352
child (349) 349
animals (338) 338
aged, 80 and over (328) 328
anti-ulcer agents - therapeutic use (328) 328
abridged index medicus (324) 324
anti-bacterial agents - adverse effects (315) 315
drug administration schedule (312) 312
antibiotic resistance (306) 306
medicine, general & internal (306) 306
erythromycin (303) 303
metronidazole - pharmacology (302) 302
children (299) 299
strains (293) 293
care and treatment (291) 291
drug therapy (290) 290
metaanalysis (285) 285
research (279) 279
macrolides (277) 277
young adult (274) 274
omeprazole - therapeutic use (272) 272
helicobacter infections - diagnosis (268) 268
analysis (265) 265
proton pump inhibitors (265) 265
mutation (260) 260
bacteria (257) 257
biopsy (257) 257
lansoprazole (251) 251
bacterial infections and mycoses (249) 249
helicobacter infections - epidemiology (239) 239
polymerase chain reaction (239) 239
antimicrobial agents (236) 236
amoxicillin - pharmacology (235) 235
proton pump inhibitors - therapeutic use (234) 234
metronidazole - administration & dosage (227) 227
clarithromycin - adverse effects (226) 226
metronidazole resistance (224) 224
drug resistance, bacterial - genetics (222) 222
in-vitro (222) 222
treatment failure (221) 221
child, preschool (220) 220
immunology (217) 217
duodenal-ulcer (216) 216
rna, ribosomal, 23s - genetics (213) 213
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4525) 4525
Japanese (105) 105
Spanish (82) 82
French (50) 50
Korean (37) 37
German (31) 31
Chinese (30) 30
Turkish (13) 13
Polish (10) 10
Russian (9) 9
Hungarian (8) 8
Portuguese (7) 7
Czech (4) 4
Dutch (4) 4
Italian (3) 3
Hebrew (2) 2
Swedish (2) 2
Danish (1) 1
Norwegian (1) 1
Persian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gut, ISSN 0017-5749, 01/2013, Volume 62, Issue 1, pp. 34 - 42
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 2010, Volume 5, Issue 3, pp. e9836 - e9836
Antibiotic administration is the standard treatment for the bacterium Helicobacter pylori, the main causative agent of peptic ulcer disease and gastric cancer.... 
CLARITHROMYCIN | RESISTANCE GENES | INTESTINAL MICROFLORA | HELICOBACTER-PYLORI INFECTION | FLORA | PERSISTENCE | BIOLOGY | POPULATIONS | MACROLIDE RESISTANCE | GRADIENT GEL-ELECTROPHORESIS | 16S RIBOSOMAL-RNA | Oligonucleotides - genetics | Dyspepsia - drug therapy | Humans | Metronidazole - administration & dosage | Omeprazole - administration & dosage | Gastrointestinal Tract - microbiology | Gastrointestinal Tract - drug effects | Drug Resistance, Microbial - genetics | Phylogeny | Case-Control Studies | Anti-Bacterial Agents - therapeutic use | Polymorphism, Restriction Fragment Length | Time Factors | Clarithromycin - administration & dosage | RNA, Ribosomal, 16S - genetics | Feces | Pharynx - drug effects | Pharynx - microbiology | Drug resistance in microorganisms | Care and treatment | Antibiotics | Microbiota (Symbiotic organisms) | RNA | Analysis | Peptic ulcer | Stomach cancer | Antiulcer drugs | Short term | Microbial activity | Clarithromycin | rRNA 16S | Microbiology | Genes | Colorectal cancer | Biology | Drug resistance | Gene polymorphism | Data bases | Microorganisms | Helicobacter pylori | Intestine | Antibiotic resistance | Phylogenetics | Bacteria | Gastric cancer | Deoxyribonucleic acid--DNA | Pharynx | Disease control | Bacteriology | Polymerase chain reaction | Infectious diseases | Restriction fragment length polymorphism | Metronidazole | Cancer | Long-term effects | Polymorphism | Index Medicus | ULCERS | ANTIBIOTICS | DISEASES | THERAPY | NEOPLASMS | GENES | FECES | COMMUNITIES | METRONIDAZOLE | Microbial/genetics | Ribosomal | Pharynx/drug effects/microbiology | Restriction Fragment Length | Gastrointestinal Tract/drug effects/microbiology | Clarithromycin/administration & dosage | Omeprazole/administration & dosage | Metronidazole/administration & dosage | Oligonucleotides/genetics | Naturvetenskap | Natural Sciences | Dyspepsia/drug therapy | 16S/genetics | Anti-Bacterial Agents/therapeutic use | Drug Resistance | Deoxyribonucleic acid | DNA
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2015, Volume 10, Issue 5, pp. e0124199 - e0124199
Objective The Taiwan Government issued a policy to restrict antimicrobial usage since 2001. We aimed to assess the changes in the antibiotic consumption and... 
TRIAL | MULTICENTER | EVOLUTION | EFFICACY | MULTIDISCIPLINARY SCIENCES | TRIPLE THERAPIES | ERADICATION THERAPY | INFECTION | PREVALENCE | 1ST-LINE | ANTIMICROBIAL RESISTANCE | Helicobacter pylori - growth & development | Humans | Tetracycline - pharmacology | Helicobacter pylori - genetics | Tetracycline - therapeutic use | Genotype | Helicobacter pylori - drug effects | Male | Clarithromycin - therapeutic use | Virulence Factors | Metronidazole - pharmacology | Anti-Bacterial Agents - therapeutic use | Amoxicillin - pharmacology | Metronidazole - therapeutic use | Helicobacter Infections - drug therapy | Amoxicillin - therapeutic use | Taiwan | Female | Anti-Bacterial Agents - pharmacology | Clarithromycin - pharmacology | Drug resistance in microorganisms | Complications and side effects | Demographic aspects | Patient outcomes | Amoxicillin | Helicobacter infections | Dosage and administration | Genetic aspects | Research | Drug therapy | Fluoroquinolones | Levofloxacin | Clarithromycin | Insurance claims | Physicians | Virulence | Infections | Males | Drug resistance | Antiinfectives and antibacterials | Consortia | Helicobacter pylori | Virulence factors | Antibiotic resistance | Gastroenterology | Consumption | Health insurance | Departments | Internal medicine | Agar | Sex differences | Antimicrobial agents | Agar dilution test | Resistance factors | Nitroimidazole | Medicine | Dilution | Hospitals | Antibiotics | Genotyping | Gastrointestinal diseases | Ulcers | Minimum inhibitory concentration | Metronidazole | Females | Index Medicus
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 4/2005, Volume 102, Issue 14, pp. 5180 - 5185
Journal Article
Journal Article
Journal of Gastrointestinal and Liver Diseases, ISSN 1841-8724, 12/2010, Volume 19, Issue 4, pp. 409 - 414
Background and Aims. Prevalence of H. pylori antibiotic resistance is increasing worldwide, and it is the main factor affecting efficacy of current therapeutic... 
Resistance | Antibiotic | Worldwide | Helicobacter pylori | antibiotic | STRAINS | RISK-FACTORS | CLARITHROMYCIN RESISTANCE | PREVALENCE | ANTIMICROBIAL RESISTANCE | resistance | THERAPY | LEVOFLOXACIN | worldwide | ERADICATION | INFECTION | GASTROENTEROLOGY & HEPATOLOGY | HELICOBACTER-PYLORI
Journal Article
Journal Article
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 07/2018, Volume 48, Issue 1, pp. 95 - 96
Linked Content This article is linked to Gatta et al and Gatta and Scarpignato papers. To view these articles visit https://doi.org/10.1111/apt.14597 and... 
GASTROENTEROLOGY & HEPATOLOGY | PHARMACOLOGY & PHARMACY | Drug Resistance, Microbial | Clarithromycin | Helicobacter Infections | Helicobacter pylori | Humans
Journal Article
Helicobacter, ISSN 1083-4389, 12/2017, Volume 22, Issue 6, pp. e12447 - n/a
Journal Article